Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer.
| Autor: | Miles, D W1, de Haas, S L2, Dirix, L Y3, Romieu, G4, Chan, A5, Pivot, X6, Tomczak, P7, Provencher, L8, Cortés, J9, Delmar, P R2, Scherer, S J10 |
|---|---|
| Zdroj: | British Journal of Cancer. 3/19/2013, Vol. 108 Issue 5, p1052-1060. 9p. 3 Diagrams, 3 Charts, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|